O-GlcNAcylation modulates Bmi-1 protein stability and potential oncogenic function in prostate cancer - Li, Y; Wang, L; Liu, J; Zhang, P; An, M; Han, C; Guan, X; Zhang, K (Oncogene, 2017)
Keywords: 13/1; 13/109; 13/2; 13/62; 38/1; 38/39; 38/61; 38/77; 38/89; 631/337/458/1524; 631/67/395; 82/1; 82/29; 82/83; Acylation; Apoptosis; Bmi protein; Care and treatment; Case-Control Studies; Cell Biology; Cell Line, Tumor; Cell self-renewal; Development and progression; DNA microarrays; Gene expression; Genetic aspects; Health aspects; Human Genetics; Humans; Immunoprecipitation; Internal Medicine; Male; Mass Spectrometry; Medicine; Medicine & Public Health; Mitogen-Activated Protein Kinase 7 - genetics; Mitogen-Activated Protein Kinase 7 - metabolism; N-Acetylglucosaminyltransferases - metabolism; O-GlcNAcylation; Oncogenes; Oncology; original-article; p53 Protein; Polycomb group proteins; Polycomb Repressive Complex 1 - genetics; Polycomb Repressive Complex 1 - metabolism; Post-translation; Prostate cancer; Prostatic Neoplasms - enzymology; Prostatic Neoplasms - genetics; Prostatic Neoplasms - metabolism; Protein Stability; Proteins; PTEN protein; Stem cells; Transcription; Transcription factors; Transfection; Tumorigenesis